amiselimod (MT 1303) / Mitsubishi Tanabe, Bausch Health  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
amiselimod (MT 1303) / Mitsubishi Tanabe, Bausch Health
NCT04857112 / 2020-005232-30: Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis

Active, not recruiting
2
322
US
Low Dose MT-1303, High Dose MT-1303, Placebo
Bausch Health Americas, Inc.
Ulcerative Colitis
09/24
09/24

Download Options